Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 2/2015

01-01-2015 | Erratum

Erratum to: Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis

Authors: C. A. Drukker, S. G. Elias, M. V. Nijenhuis, J. Wesseling, H. Bartelink, P. Elkhuizen, B. Fowble, P. W. Whitworth, R. R. Patel, F. A. de Snoo, L. J. van’t Veer, P. D. Beitsch, E. J. Th. Rutgers

Published in: Breast Cancer Research and Treatment | Issue 2/2015

Login to get access

Excerpt

In the original publication of the article, the electronic supplementary material was omitted inadvertently. It has been included and a link to access it is provided in this erratum. …
Appendix
Available only for authorised users
Metadata
Title
Erratum to: Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis
Authors
C. A. Drukker
S. G. Elias
M. V. Nijenhuis
J. Wesseling
H. Bartelink
P. Elkhuizen
B. Fowble
P. W. Whitworth
R. R. Patel
F. A. de Snoo
L. J. van’t Veer
P. D. Beitsch
E. J. Th. Rutgers
Publication date
01-01-2015
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2015
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-015-3264-z

Other articles of this Issue 2/2015

Breast Cancer Research and Treatment 2/2015 Go to the issue

Preclinical study

Long-term clinical outcomes in women with breast pain in the absence of additional clinical findings: mammography remains indicated

Epidemiology

Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis

Preclinical Study

Luminal progenitor and fetal mammary stem cell expression features predict breast tumor response to neoadjuvant chemotherapy

Preclinical study

INPP4B and RAD50 have an interactive effect on survival after breast cancer

Brief Report

Invasive lobular carcinoma of the breast: local recurrence after breast-conserving therapy by subtype approximation and surgical margin

Preclinical study

Divergent roles of CXCR3 isoforms in promoting cancer stem-like cell survival and metastasis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits